Calton & Associates Inc. purchased a new stake in shares of National HealthCare Co. (NYSEAMERICAN:NHC) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 50,367 shares of the company’s stock, valued at approximately $3,193,000. National HealthCare makes up 0.8% of Calton & Associates Inc.’s investment portfolio, making the stock its 19th biggest position. Calton & Associates Inc. owned 0.33% of National HealthCare as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in NHC. Vanguard Group Inc. boosted its holdings in shares of National HealthCare by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 889,216 shares of the company’s stock worth $62,369,000 after buying an additional 21,666 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of National HealthCare by 4.7% in the 3rd quarter. Dimensional Fund Advisors LP now owns 554,532 shares of the company’s stock worth $34,697,000 after buying an additional 24,685 shares during the last quarter. State Street Corp lifted its holdings in National HealthCare by 6.4% during the second quarter. State Street Corp now owns 283,960 shares of the company’s stock valued at $19,913,000 after purchasing an additional 17,106 shares during the last quarter. Northern Trust Corp lifted its holdings in National HealthCare by 10.4% during the second quarter. Northern Trust Corp now owns 242,824 shares of the company’s stock valued at $17,032,000 after purchasing an additional 22,947 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its holdings in National HealthCare by 2.8% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 48,397 shares of the company’s stock valued at $2,950,000 after purchasing an additional 1,325 shares during the last quarter.
In other news, SVP Jeffrey Russell Smith sold 1,499 shares of the stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $67.06, for a total transaction of $100,522.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Separately, BidaskClub downgraded shares of National HealthCare from a “sell” rating to a “strong sell” rating in a report on Tuesday, November 7th.
National HealthCare Co. (NYSEAMERICAN NHC) opened at $62.73 on Tuesday. National HealthCare Co. has a 52-week low of $57.00 and a 52-week high of $75.70. The firm has a market cap of $965.77, a P/E ratio of 19.60 and a beta of 0.40.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.thelincolnianonline.com/2018/02/20/calton-associates-inc-purchases-new-position-in-national-healthcare-co-nhc-updated-updated.html.
National HealthCare Profile
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer’s care, senior living services, and home healthcare services.
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.